Concepedia
Statistics
Publications
2
Citations
170
H-Index
Active since
2017
Affiliations
Radboud University Medical Center(Current)
Radboud University Nijmegen
Iris L. van Ingen is an author at Radboud University Medical Center.
Publications per year
2017–2023
Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open‐Label Transition From Reference Infliximab to Biosimilar Infliximab
Lieke Tweehuysen, Bart J. F. van den Bemt, Iris L. van Ingen et al. · Arthritis & Rheumatology · 2017 · 160 citations
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion
Theodoros Ioannis Papadimitriou, Prashant Singh, A. van Caam et al. · Annals of the Rheumatic Diseases · 2023 · 10 citations · Full text
1–2 of 2